ReviewCureus2025
Pharmacological Interactions Between Nutritional Supplements and Prescription Medications in Older Adults: A Comprehensive Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Association of nutrient supplement use in older adults with chronic diseases: a cross-sectional study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global aging population faces increasing risks of supplement-drug interactions due to rising polypharmacy and widespread use of nutritional supplements. Older adults, particularly those with chronic conditions, frequently combine prescription medications with dietary supplements, yet healthcare providers often overlook these interactions, leading to preventable adverse effects. This review synthesizes evidence from 16 international studies spanning nearly three decades, examining the intersection of supplement and medication use in older adults. Key findings reveal a high prevalence of concurrent use (23-82.5%), significantly increasing the likelihood of adverse interactions, particularly with antithrombotics (e.g., warfarin and ginkgo) and absorption-disrupting minerals (e.g., calcium and levothyroxine). A critical systemic failure in patient-provider communication exacerbates these risks, as clinicians often neglect to inquire about supplement use. Despite widespread potential interactions, actual clinical harm appears concentrated in high-risk combinations. The review calls for proactive clinical strategies, including standardized supplement screening, targeted patient education, and pharmacist-led medication management. Its limitations include cross-sectional study designs and self-reported data, underscoring the need for longitudinal and intervention-based research. Future studies should prioritize causal evidence, standardized methodologies, and data from low- and middle-income countries to mitigate risks in aging populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.